Last reviewed · How we verify
Salbutamol Aerosol
At a glance
| Generic name | Salbutamol Aerosol |
|---|---|
| Also known as | Ammonium bromide bromide aerosol |
| Sponsor | snow |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma (PHASE2)
- Clinical Assessment of Acupuncture for the Treatment of Chronic Asthma (NA)
- Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care (PHASE4)
- Beta Agonist Nebulization in Non Invasively Ventilated COPD Patients: Safety, and Therapeutic Efficacy Range. (PHASE2)
- National Cohort of Subjects at Risk of Developing Rheumatoid Arthritis
- A Study to Investigate the Effects of PT027 (Budesonide/Albuterol Sulfate) Metered-dose Inhaler Compared With Placebo on Exercise-Induced Bronchoconstriction in Adult Patients With Asthma (PHASE3)
- Microbiote's Evolution After Use of Nitrous Oxide on Pediatric Patient Needing Airway Samples (PHASE3)
- BE Study of Albuterol Sulfate Inhalation Aerosol 90 mcg Per Actuation in Patients With Stable Mild Asthma (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Salbutamol Aerosol CI brief — competitive landscape report
- Salbutamol Aerosol updates RSS · CI watch RSS
- snow portfolio CI